Metlife Overview
Metlife Target Price
Analysts' 12-month price predictions for MET.
Share Price
$80.65
Average Target Price
$94.00
16.6% upside
16.6% upside1 analysts in the last 4 months
High: $94 | Low: $94
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-02 | Piper SandlerJohn Barnidge | $94 | 16.6% upside |  |
| 2025-02-28 | Morgan Stanley | $109 | 35.2% upside | |
| 2024-10-02 | Piper SandlerJohn Barnidge | $92 | 14.1% upside | |
| 2024-09-04 | BarclaysAlex Scott | $91 | 12.8% upside | |
| 2024-08-01 | Bank of America SecuritiesJoshua Shanker | $96 | 19% upside | |
| 2024-07-10 | Morgan StanleyBob Huang | $83 | 2.9% upside | |
| 2024-05-22 | Argus ResearchKevin Heal | $80 |  0.8% downside | |
| 2024-05-06 | Piper SandlerJohn Barnidge | $82 | 1.7% upside | |
| 2024-03-13 | CFRACatherine Seifert | $77 | 4.5% downside | |
| 2024-01-08 | Goldman SachsAlex Scott | $80 | 0.8% downside | |
| 2023-09-14 | Mizuho SecuritiesBrett Linzey | $145 | 79.8% upside | |
| 2023-02-02 | Morgan Stanley | $90 | 11.6% upside | |
| 2023-01-10 | Morgan Stanley | $88 | 9.1% upside | |
| 2023-01-09 | Goldman Sachs | $78 | 3.3% downside | |
| 2023-01-06 | J.P. Morgan | $80 | 0.8% downside | |
| 2022-12-09 | Jefferies | $82 | 1.7% upside | |
| 2022-11-17 | Morgan Stanley | $87 | 7.9% upside | |
| 2022-08-22 | Credit Suisse | $77 | 4.5% downside | |
| 2022-08-17 | Morgan Stanley | $83 | 2.9% upside | |
| 2022-08-04 | Morgan Stanley | $79 | 2% downside | |
| 2022-07-14 | Barclays | $75 | 7% downside | |
| 2022-07-06 | Evercore ISI | $80 | 0.8% downside | |
| 2022-07-06 | Morgan Stanley | $78 | 3.3% downside | |
| 2022-06-22 | Wolfe ResearchCharles Lederer | $74 | 8.2% downside | |
| 2022-05-05 | Morgan Stanley | $80 | 0.8% downside | |
| 2022-01-05 | Evercore ISIThomas Gallagher | $75 | 7% downside | |
| 2021-12-02 | Goldman SachsAlex Scott | $77 | 4.5% downside | |
| 2021-05-13 | Credit SuisseAndrew Kligerman | $68 | 15.7% downside | |
| 2021-05-07 | Argus ResearchKevin Heal | $72 | 10.7% downside | |